Alexander Lila: “The doctor always has an option to choose the optimal genetically engineered biological drug to treat a patient with rheumatoid arthritis”

Abstract

Interview with Alexander M. Lila, Dr. of Sci. (Med.), Professor, Director of Federal State Budgetary Scientific Institution V.A. Nasonova Research Institute of Rheumatology, Head of Department of Rheumatology, Russian Medical Academy of Continuing Postgraduate Education, Corresponding Member of the Russian Academy of Sciences.